kynurenine has been researched along with Viremia in 2 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Viremia: The presence of viruses in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avelino-Silva, VI | 1 |
| Miyaji, KT | 1 |
| Hunt, PW | 1 |
| Huang, Y | 1 |
| Simoes, M | 1 |
| Lima, SB | 1 |
| Freire, MS | 1 |
| Caiaffa-Filho, HH | 1 |
| Hong, MA | 1 |
| Costa, DA | 1 |
| Dias, JZ | 1 |
| Cerqueira, NB | 1 |
| Nishiya, AS | 1 |
| Sabino, EC | 1 |
| Sartori, AM | 1 |
| Kallas, EG | 1 |
| Boasso, A | 1 |
| Vaccari, M | 1 |
| Fuchs, D | 1 |
| Hardy, AW | 1 |
| Tsai, WP | 1 |
| Tryniszewska, E | 1 |
| Shearer, GM | 1 |
| Franchini, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Immunogenicity and Safety of the CoronaVac Vacccine in Patients With Autoimmune Rheumatic Diseases and People Living With HIV/AIDS[NCT04754698] | Phase 4 | 2,067 participants (Anticipated) | Interventional | 2021-02-09 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for kynurenine and Viremia
| Article | Year |
|---|---|
CD4/CD8 Ratio and KT Ratio Predict Yellow Fever Vaccine Immunogenicity in HIV-Infected Patients.
Topics: Adult; Antibodies, Neutralizing; Antibodies, Viral; CD4-CD8 Ratio; Female; HIV Infections; Humans; I | 2016 |
Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques.
Topics: Animals; Anti-Retroviral Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; En | 2009 |